Literature DB >> 1283361

Is digital screening for prostatic cancer effective?

D B Louria1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1283361      PMCID: PMC1808004     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN: 0028-7091


× No keyword cloud information.
  9 in total

1.  Prostate specific antigen. Experimental and clinical observations.

Authors:  P R Huber; Y Schnell; F Hering; G Rutishauser
Journal:  Scand J Urol Nephrol Suppl       Date:  1987

2.  Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

Authors:  T A Stamey; N Yang; A R Hay; J E McNeal; F S Freiha; E Redwine
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

Review 3.  The efficacy of screening for carcinoma of the prostate by digital examination.

Authors:  R R Love
Journal:  Am J Prev Med       Date:  1985 Nov-Dec       Impact factor: 5.043

4.  VACURG randomised trial of radical prostatectomy for stages I and II prostatic cancer. Veterans Administration Cooperative Urological Research Group.

Authors:  D P Byar; D K Corle
Journal:  Urology       Date:  1981-04       Impact factor: 2.649

5.  Assessment of screening for prostate cancer using the digital rectal examination.

Authors:  G W Chodak; P Keller; H W Schoenberg
Journal:  J Urol       Date:  1989-05       Impact factor: 7.450

6.  Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup.

Authors:  J I Epstein; G Paull; J C Eggleston; P C Walsh
Journal:  J Urol       Date:  1986-10       Impact factor: 7.450

7.  Radical perineal prostatectomy for clinical stage B2 carcinoma of the prostate.

Authors:  J S Elder; H J Jewett; P C Walsh
Journal:  J Urol       Date:  1982-04       Impact factor: 7.450

8.  Prostatic evaluation by transrectal sonography with histopathologic correlation: the echopenic appearance of early carcinoma.

Authors:  W F Dähnert; U M Hamper; J C Eggleston; P C Walsh; R C Sanders
Journal:  Radiology       Date:  1986-01       Impact factor: 11.105

9.  Impact of routine screening for adenocarcinoma of the prostate on stage distribution.

Authors:  I M Thompson; J B Rounder; J L Teague; M Peek; C R Spence
Journal:  J Urol       Date:  1987-03       Impact factor: 7.450

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.